DermaPlus, Inc. Offers Tropoelastin to Organizations Engaged in Organ and Tissue Regeneration
Posted on: Tuesday, 14 November 2006, 12:01 CST
DermaPlus, Inc. is offering research quantities of its laboratory synthesized human Tropoelastin to qualified organizations engaged in organ and tissue regeneration research. The Company's version of Tropoelastin, trademarked Elastatropin, can be used as a cost-effective and reliable scaffold material and connective matrix to bind and reinforce cells when growing cells into organ-like masses. The DermaPlus business model in place is using revenue from their successful DermaLastyl skin cream products to make plentiful quantities of Tropoelastin/Elastatropin available for organ and tissue regeneration research.
Dr. Burt Ensley, DermaPlus CEO notes, "Tropoelastin/Elastatropin is the perfect material for these organ and tissue regeneration projects, and existing and future customers can contribute and support the advance of medical science when they purchase a jar of our very successful DermaLastyl skin cream. Other sophisticated synthesized human matrix proteins that could be similarly used to maintain the integrity and shape of an organ can cost up to $1 million per gram. Our Company, with the help of its customers, is offering low-cost Elastatropin on a case-by-case basis to qualified organizations to expedite organ and tissue regeneration projects."
Elastatropin is currently used to reduce wrinkles in the successful DermaLastyl line of Face and Eye serum products. Elastatropin is a complex chain of 600 amino acids in a patented molecular delivery system to restore elastic properties to skin. It is successfully reducing wrinkles by penetrating the deepest parts of the topmost layer of skin, entering into the outer skin layers, cross-linking with existing elastin and other skin matrix proteins and expanding the flexible backbone of the skin.
For further information, qualified organ and tissue regeneration research organizations should call 800-335-8312.
About DermaPlus
DermaPlus, Inc., a Biotechnology Company, makes and sells DermaLastyl, an anti-aging skin cream that contains the exclusive ingredient Elastatropin - a synthetic form of human elastin. DermaPlus has developed a process for making this priceless synthetic molecule in laboratory organisms and incorporates the purified material into its highly successful Face and Eye serum products DermaLastyl-B face cream and DermaLastyl-E eye cream. Available only at DermaLastyl.com.
Source: Business Wire
Related Articles
- Stratatech Successfully Completes Clinical Trial of StrataGraft(R) Skin Substitute
- Study Assays Marrow Transplant Troubles
- Listeria Found in Unpasturized Cream
- Friendly Ice Cream Corporation Announces Successful Completion of Consent Solicitation
- New Hydrogel Can Repair, Regenerate Tissue
- Eugene Bell, Skin Graft Developer, Dies
- Mapping System Tells Skin Cells Whether to Become Scalp, Palm Tissues, Stanford Study Finds
- Help for Damaged Liver
- Per-Se Technologies Names Chris Perkins Chief Operating Officer; Organizes Operations to Support the Financial Success of Healthcare Providers
- Holding It All Together
User Comments (0)

RSS Feeds